Navigation Links
Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
Date:8/4/2009

VANCOUVER, Aug. 4 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced the launch of a series of new, proprietary Quill(TM) SRS product codes specifically designed for laparoscopic, or minimally invasive, gynecology procedures, including hysterectomies and myomectomies. In 2008, there were approximately 750,000 hysterectomies performed in the United States of which approximately 130,000 were performed laparoscopically. In addition, there were approximately 72,000 myomectomies performed in the United States to remove uterine fibroid tumors. Management estimates 6-8% annual growth in laparoscopically assisted hysterectomies through 2014.

Angiotech's proprietary Quill SRS barbed suture technology offers significant advantages in laparoscopic surgery whether performed manually by surgeons or through robotic assistance. The primary advantage of Quill SRS for laparoscopic procedures is the ability to close a wound using Quill without the surgeon having to tie knots. The exercise of tying knots can be very challenging and time consuming when surgeons are relegated to operating in a smaller surgical field as a result of electing to use a minimally invasive approach for the procedure. A second advantage is to minimize or eliminate the need for a third hand to maintain tension on the suture as typically required with a traditional suturing technique in order to deal with tissue recoil. A third advantage of Quill SRS is that the even distribution of tension and its ability to maintain the tension along the length of the suture also provides hemostatic benefits, often eliminating or minimizing the need for standard hemostatic sutures.

These and other novel elements of Angiotech's Quill SRS for laparoscopic and robotic-assisted surgery are expected to significantly reduce the time and difficulty of completing a wound
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Research ... "Global Cell Culture Market 2014-2018" report to ... Cell culture is the in vitro growth ... as research, cell studies, and biopharmaceutical production. Cell culture ... production. Cell culture instruments and cell culture consumables are ...
(Date:7/24/2014)... California (PRWEB) July 24, 2014 ... to advances in modeling lithium-ion battery storage capacity. ... benefit from a theoretical model created at ... University that predicts how carbon components will ... energy storage emphasizes the urgent need for higher-performance ...
(Date:7/24/2014)... 24, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... notice on July 18, 2014 from the NYSE ... the CorMedix plan to regain compliance with continued ... the NYSE-MKT is continuing the Company,s listing and ...
(Date:7/24/2014)... 24, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Sulphate basic information, including its definition, classification, ... This research covers the international market analysis, including ... analysis covering macroeconomic environment & economic situation analysis, ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2Getting More Life out of Lithium-ion Batteries 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... Valencia (UV) has confirmed that the substance used to hermetically ... was pine resin. The scientists also studied the metallic fragments ... used for iron-working. In 2005, a group of archaeologists ... at Lixus, an ancient settlement founded by the Phoenicians near ...
... CRANBURY, N.J. , Feb. 5 Amicus Therapeutics ... has elected John F. Crowley as Chairman of the ... (CEO), effective immediately.  Mr. Crowley will succeed Donald J. Hayden, ... Board. , "The Board,s decision to elect Mr. Crowley as Chairman ...
... Stuart Lindsay, Arizona State University Regents, professor and director ... has just released the first comprehensive guide to a ... grain of sand. Introduction to Nanoscience (published by ... an emerging discipline which has in recent years, produced ...
Cached Biology Technology:Chemical analyses uncover secrets of an ancient amphora 2Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board 2Big book explores a small world: Stuart Lindsay's guide to nanoscience 2Big book explores a small world: Stuart Lindsay's guide to nanoscience 3
(Date:7/24/2014)... Scientists at The New York Stem Cell ... to creating a viable cell replacement therapy for ... , For the first time, NYSCF scientists generated ... samples of patients with primary progressive multiple sclerosis ... induce these stem cells into becoming oligodendrocytes, the ...
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... factors that characterize sustainable university and college programs ... physics teachers. Specifically, one or more faculty members ... combination with institutional motivation and commitment can ensure ... and Math (STEM) teacher shortages are especially acute ... for institutions seeking to increase the number of ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Creating sustainable STEM teacher preparation programs 2
... his research team at the Centre for Stem Cell Research ... ( http://dev.biologists.org/ ) a new and safer way of ... give rise to every tissue of the body. Rapid developments ... way for stem cell scientists to convert specialised cells, such ...
... Just the mention of this iconic spring and early ... drinks and sweet desserts. Researchers interested in learning more ... of strawberries, a strong influence on consumer preferences, is ... texture, and appearance. The goals of a recent ...
... most often as a healthy, convenient food, are also ... plants are highly prized by many as one of ... ambiance in gardens and pool environments. A research ... journal HortTechnology detailed a study of 33 ...
Cached Biology News:Researchers piggyback to safer reprogrammed stem cells 2Analysis of fresh strawberries reveals consumer preferences 2